Nome |
# |
Robot-assisted laparoscopic vs open gastrectomy for gastric cancer: Systematic review and meta-analysis, file e0feeaa7-a926-44d2-e053-6605fe0a8db0
|
173
|
PIK3CA mutation in gastric cancer and the role of microsatellite instability status in mutations of exons 9 and 20 of the PIK3CA gene, file e0feeaa7-a434-44d2-e053-6605fe0a8db0
|
165
|
Comparison between 7th and 8th edition of AJCC TNM staging system for gastric cancer: Old problems and new perspectives, file e0feeaa8-0da5-44d2-e053-6605fe0a8db0
|
156
|
Gastric cancer maximum tumour diameter reduction rate at CT examination as a radiological index for predicting histopathological regression after neoadjuvant treatment: A multicentre GIRCG study, file e0feeaa7-9ecb-44d2-e053-6605fe0a8db0
|
153
|
Sample handling of gastric tissue and O-glycan alterations in paired gastric cancer and non-tumorigenic tissues, file e0feeaa7-9d10-44d2-e053-6605fe0a8db0
|
149
|
Robotic versus laparoscopic gastrectomy for gastric cancer: an umbrella review of systematic reviews and meta-analyses, file e0feeaaa-4935-44d2-e053-6605fe0a8db0
|
148
|
Diagnosis and treatment of primary hypertrophic pyloric stenosis (HPS) in older children, file e0feeaaa-105a-44d2-e053-6605fe0a8db0
|
131
|
Profiling critical cancer gene mutations in clinical tumor samples., file e0feeaa4-d516-44d2-e053-6605fe0a8db0
|
128
|
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients, file e0feeaa7-a9dc-44d2-e053-6605fe0a8db0
|
122
|
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts, file e0feeaa7-ab0f-44d2-e053-6605fe0a8db0
|
119
|
Robot-assisted laparoscopic gastrectomy for gastric cancer, file e0feeaa7-aa22-44d2-e053-6605fe0a8db0
|
117
|
Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis, file e0feeaa7-9fe4-44d2-e053-6605fe0a8db0
|
114
|
From digital world to real life: A robotic approach to the esophagogastric junction with a 3D printed model, file e0feeaa8-8f74-44d2-e053-6605fe0a8db0
|
114
|
A targeted proteomics approach reveals a serum protein signature as diagnostic biomarker for resectable gastric cancer, file e0feeaaa-55cf-44d2-e053-6605fe0a8db0
|
101
|
Clinical Outcome of Primary and Postoperative Visceral Perforations, file e0feeaa7-913d-44d2-e053-6605fe0a8db0
|
96
|
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: A randomized phase-II trial, file e0feeaa9-8e50-44d2-e053-6605fe0a8db0
|
84
|
Robotic versus laparoscopic gastrectomy for gastric cancer: protocol for umbrella review of systematic reviews and meta-analyses, file e0feeaa9-a7ad-44d2-e053-6605fe0a8db0
|
70
|
Pathology Characteristics that Optimize Outcome Prediction of T1N0M0 Breast Cancer, file e0feeaa7-5c7a-44d2-e053-6605fe0a8db0
|
68
|
Anatomical vs. Wedge Hepatic Resection. Our Experience about 31 Consecutive Patients with Hepatic Metastases from Colorectal Cancer, file e0feeaa7-63c6-44d2-e053-6605fe0a8db0
|
67
|
Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases, file e0feeaa4-bdcc-44d2-e053-6605fe0a8db0
|
57
|
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal Surface Malignancies Oncoteam—S.I.C.O.’, file e0feeaaa-39c6-44d2-e053-6605fe0a8db0
|
51
|
Experimental Studies on the Modification of Urinary Alanine Aminopeptidase (AAP) and N-Acetyl--D-Glucosaminidase (NAG) in Patients Submitted to Intraperitoneal Hyperthermic Chemoperfusion (HIIP), file e0feeaa7-63c2-44d2-e053-6605fe0a8db0
|
36
|
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study, file e0feeaab-cf9b-44d2-e053-6605fe0a8db0
|
31
|
Assessment of Microsatellite Instability in Familial Gastric Cancer, file e0feeaa7-9050-44d2-e053-6605fe0a8db0
|
28
|
Treatment of Advanced Ovarian Cancer by Neoadjuvant Chemotherapy Followed by Surgical Debulking and Intraperitoneal Chemohyperthermia, file e0feeaa7-9041-44d2-e053-6605fe0a8db0
|
27
|
Clinical Utility of Serum Tumor Markers Assay in Patients Admitted for Intestinal Occlusion, file e0feeaa7-5c79-44d2-e053-6605fe0a8db0
|
20
|
Age Related Co-Morbidities in Colorectal Cancer Patients: Surgical Problems and Prognostic Impact, file e0feeaa7-913e-44d2-e053-6605fe0a8db0
|
20
|
Treatment of Peritoneal Carcinomatosis withCytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Personal Experience of the First 100 Cases, file e0feeaa7-90e9-44d2-e053-6605fe0a8db0
|
19
|
Correlation between Jaundice and CA 19–9 Serum Levels in Benign and Malignant Conditions, file e0feeaa7-5f18-44d2-e053-6605fe0a8db0
|
17
|
Petersen Index Score in Dukes’ B Colorectal Cancer. Our Experience on 210 Consecutive Patients, file e0feeaa7-90ed-44d2-e053-6605fe0a8db0
|
15
|
Preoperative Value of Serum 19-9 Levels in Predicting Resectability and Prognosis in Pancreatic Cancer, file e0feeaa7-90ec-44d2-e053-6605fe0a8db0
|
14
|
Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project, file e0feeaa9-bb21-44d2-e053-6605fe0a8db0
|
14
|
The Emergency Surgery Frailty Index (EmSFI) in Elderly Patients with Acute Appendicitis: An External Validation of Prognostic Score, file 316a1daa-19ca-4a1e-b019-cbf780b8fa4a
|
13
|
Gastric duplication presenting as partial gastric outlet obstruction, file e0feeaa9-2c23-44d2-e053-6605fe0a8db0
|
11
|
EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative, file 13a3527b-6534-4985-b34b-7d8110368ef4
|
10
|
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status, file e0feeaa7-aa26-44d2-e053-6605fe0a8db0
|
7
|
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab, file e0feeaa5-aab8-44d2-e053-6605fe0a8db0
|
5
|
Potential impact of molecular classification on tailored lymphadenectomy for gastric cancer, file e0feeaa7-ab0e-44d2-e053-6605fe0a8db0
|
5
|
Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry, file e0feeaa7-a436-44d2-e053-6605fe0a8db0
|
4
|
KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status, file e0feeaa7-d918-44d2-e053-6605fe0a8db0
|
4
|
Gene Regulatory Network Characterization of Gastric Cancer’s Histological Subtypes: Distinctive Biological and Clinically Relevant Master Regulators, file e349b60e-ea25-4253-be3b-2dff087d65df
|
4
|
Clinical and oncological value of preoperative BMI in gastric cancer patients: A single center experience, file e0feeaa5-7402-44d2-e053-6605fe0a8db0
|
3
|
C-Met targeting in advanced gastric cancer: An open challenge, file e0feeaa5-746b-44d2-e053-6605fe0a8db0
|
3
|
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer, file e0feeaa5-be1e-44d2-e053-6605fe0a8db0
|
3
|
Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project, file e0feeaa5-be24-44d2-e053-6605fe0a8db0
|
3
|
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer, file e0feeaa5-bf0f-44d2-e053-6605fe0a8db0
|
3
|
The role of HIPEC in gastric cancer, file e0feeaa7-9d14-44d2-e053-6605fe0a8db0
|
3
|
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study, file e0feeaa9-6771-44d2-e053-6605fe0a8db0
|
3
|
Re-evaluation of Mannheim prognostic index in perforative peritonitis: Prognostic role of advanced age. A prospective cohort study, file e0feeaa4-bc7e-44d2-e053-6605fe0a8db0
|
2
|
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: a prospective single-center study., file e0feeaa4-d061-44d2-e053-6605fe0a8db0
|
2
|
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data, file e0feeaa4-d59e-44d2-e053-6605fe0a8db0
|
2
|
Subtotal gastrectomy as treatment for distal multifocal early gastric cancer, file e0feeaa4-debf-44d2-e053-6605fe0a8db0
|
2
|
Naso-gastric or naso-jejunal decompression after partial distal gastrectomy for gastric cancer. Final results of a multicenter prospective randomized trial, file e0feeaa5-7430-44d2-e053-6605fe0a8db0
|
2
|
Computed Tomographic Evaluation of Mesentery : Diagnostic Value in Acute Mesenteric Ischemia., file e0feeaa5-99b8-44d2-e053-6605fe0a8db0
|
2
|
Imagine a world without cancer, file e0feeaa5-bded-44d2-e053-6605fe0a8db0
|
2
|
Gastric cancer: Current status of lymph node dissection, file e0feeaa5-be26-44d2-e053-6605fe0a8db0
|
2
|
null, file e0feeaa5-be27-44d2-e053-6605fe0a8db0
|
2
|
null, file e0feeaa5-be29-44d2-e053-6605fe0a8db0
|
2
|
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015, file e0feeaa5-c221-44d2-e053-6605fe0a8db0
|
2
|
Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG study, file e0feeaa5-c36a-44d2-e053-6605fe0a8db0
|
2
|
Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience, file e0feeaa5-c625-44d2-e053-6605fe0a8db0
|
2
|
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives, file e0feeaa5-c626-44d2-e053-6605fe0a8db0
|
2
|
VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort, file e0feeaa5-c649-44d2-e053-6605fe0a8db0
|
2
|
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study, file e0feeaa6-3854-44d2-e053-6605fe0a8db0
|
2
|
Soluble E-Cadherin Level in Gastric Cancer Patients, file e0feeaa7-5c7b-44d2-e053-6605fe0a8db0
|
2
|
International consensus on a complications list after gastrectomy for cancer, file e0feeaa7-9fa4-44d2-e053-6605fe0a8db0
|
2
|
Complications after gastrectomy for cancer: Italian perspective, file e0feeaa7-9fe7-44d2-e053-6605fe0a8db0
|
2
|
Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO), file e0feeaa7-a928-44d2-e053-6605fe0a8db0
|
2
|
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer, file e0feeaa9-9950-44d2-e053-6605fe0a8db0
|
2
|
Nonocclusive visceral ischemia in patients with acute aortic dissection., file e0feeaa4-d052-44d2-e053-6605fe0a8db0
|
1
|
Changing clinical and pathological features of gastric cancer over time., file e0feeaa4-d519-44d2-e053-6605fe0a8db0
|
1
|
Trattamento della carcinosi peritoneale mediante citoriduzione chirurgica e chemioipertermia intraperitoneale. [Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy], file e0feeaa4-dccf-44d2-e053-6605fe0a8db0
|
1
|
Prospective study of peritoneal recurrence after curative surgery for gastric cancer, file e0feeaa4-df00-44d2-e053-6605fe0a8db0
|
1
|
Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-ray cross-complementing group 1 (XRCC1)., file e0feeaa4-e187-44d2-e053-6605fe0a8db0
|
1
|
Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients., file e0feeaa4-e307-44d2-e053-6605fe0a8db0
|
1
|
Prevalence of factor V Leiden and prothrombin G20210A in patients with gastric cancer, file e0feeaa4-e32a-44d2-e053-6605fe0a8db0
|
1
|
Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2, file e0feeaa4-e6f1-44d2-e053-6605fe0a8db0
|
1
|
Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer., file e0feeaa4-e762-44d2-e053-6605fe0a8db0
|
1
|
The CHOLEGAS study: multicentric randomized, blinded, controlled trial of gastrectomy plus prophylactic cholecystectomy versus gastrectomy only, in adults submitted to gastric cancer surgery with curative intent., file e0feeaa4-e930-44d2-e053-6605fe0a8db0
|
1
|
Duodenal gastrointestinal stromal tumor: From clinicopathological features to surgical outcomes, file e0feeaa5-7405-44d2-e053-6605fe0a8db0
|
1
|
Follow-up after gastrectomy for cancer: Results of an international web round table, file e0feeaa5-7a45-44d2-e053-6605fe0a8db0
|
1
|
Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection?, file e0feeaa5-7cfe-44d2-e053-6605fe0a8db0
|
1
|
E-cadherin germline mutation carriers: clinical management and genetic implications, file e0feeaa5-7d27-44d2-e053-6605fe0a8db0
|
1
|
A new way to experience the International Gastric Cancer Association Congress: the Web Round Tables, file e0feeaa5-7fcf-44d2-e053-6605fe0a8db0
|
1
|
Follow-up after gastrectomy for cancer: An appraisal of the Italian research group for gastric cancer, file e0feeaa5-7fd0-44d2-e053-6605fe0a8db0
|
1
|
Gastric stump cancer after distal gastrectomy for benign disease: Clinicopathological features and surgical outcomes, file e0feeaa5-81b9-44d2-e053-6605fe0a8db0
|
1
|
Short-term and long-term risk factors in gastric cancer, file e0feeaa5-82a8-44d2-e053-6605fe0a8db0
|
1
|
HERG1 channels regulate VEGF-A secretion in human gastric cancer: Clinicopathological correlations and therapeutical implications, file e0feeaa5-8f37-44d2-e053-6605fe0a8db0
|
1
|
Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: preliminary analysis of a multicentre study, file e0feeaa5-bd78-44d2-e053-6605fe0a8db0
|
1
|
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer, file e0feeaa5-bd7b-44d2-e053-6605fe0a8db0
|
1
|
The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer, file e0feeaa5-bdeb-44d2-e053-6605fe0a8db0
|
1
|
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience, file e0feeaa5-bdef-44d2-e053-6605fe0a8db0
|
1
|
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status, file e0feeaa5-bdf0-44d2-e053-6605fe0a8db0
|
1
|
null, file e0feeaa5-bdf2-44d2-e053-6605fe0a8db0
|
1
|
null, file e0feeaa5-bdf4-44d2-e053-6605fe0a8db0
|
1
|
null, file e0feeaa5-bdf6-44d2-e053-6605fe0a8db0
|
1
|
null, file e0feeaa5-be21-44d2-e053-6605fe0a8db0
|
1
|
MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion, file e0feeaa5-be22-44d2-e053-6605fe0a8db0
|
1
|
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer, file e0feeaa5-be52-44d2-e053-6605fe0a8db0
|
1
|
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer, file e0feeaa5-c223-44d2-e053-6605fe0a8db0
|
1
|
Totale |
2.781 |